Bangs Laboratories, Inc.

Dublin, June 04, 2021 (GLOBE NEWSWIRE) -- The "Microspheres Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global microspheres market reached a value of US$ 4.6 Billion in 2020. Microspheres refer to solid sphere-shaped particles available in sizes ranging from 1 to 1000 m. They are usually made using glass, ceramic, fly ash, metal and polymers and have controlled opacity, particle size distribution, gravity and electrostatic charge. In the medical sector, microspheres are used for drug administration and embolization, along with testing and development of medical equipment. They are lightweight, have portability and high compression abilities owing to which, they are used in the production of elastics, plastics, steel, automobiles, beauty care and personal care products. They are also used for developing low thickness boring liquid and concrete slurry for oil and gas extraction activities. In addition, they find extensive applications across aviation, aerospace, defense and construction sectors.The thriving pharmaceutical and medical industries, along with the growing need for advanced drug delivery systems, is the key factor driving the growth of the market. Furthermore, microspheres are gaining traction for bone tissue engineering and radioembolization to treat liver cancer, along with the development of biopharmaceuticals. In the oil and gas industry, they are used for torque control in drilling fluids and mud lubricity in drilling machines. There is also an increase in the demand for paints and powder coatings that utilize microspheres for their high strength, low viscosity, gloss control and radiation curable properties. Moreover, factors including growing spending capacity of consumers, increasing research and development (R&D) in life sciences and biotechnology and the growing prevalence of lifestyle diseases are also favoring the market growth. Looking forward, the publisher expects the global microspheres market to grow at a CAGR of 8.50% during 2021-2026.Report Coverage: Market Breakup by Type: Market Breakup by Raw Material: Market Breakup by Application: Market Breakup by Region: Competitive Landscape:The report has also analyzed the competitive landscape of the market with some of the key players being 3M, AkzoNobel, Nouryon, Matsumoto Yushi-Seiyaku Company, Chase Corporation, Trelleborg, Momentive Performance Materials, Potters Industries, Luminex Corporation, Merit Medical Systems, Bangs Laboratories, Cospheric, Asia Pacific Microspheres, Mo-Sci Corporation, Sigmund Lindner, SIR-Spheres, etc.Key Topics Covered: 1 Preface2 Scope and Methodology3 Executive Summary4 Introduction4.1 Overview4.2 Key Industry Trends5 Global Microspheres Market5.1 Market Overview5.2 Market Performance5.3 Impact of COVID-195.4 Market Breakup by Type5.5 Market Breakup by Raw Material5.6 Market Breakup by Application5.7 Market Breakup by Region5.8 Market Forecast6 Market Breakup by Type6.1 Hollow6.1.1 Market Trends6.1.2 Market Forecast6.2 Solid6.2.1 Market Trends6.2.2 Market Forecast7 Market Breakup by Raw Material7.1 Glass7.1.1 Market Trends7.1.2 Market Forecast7.2 Ceramic7.2.1 Market Trends7.2.2 Market Forecast7.3 Fly Ash7.3.1 Market Trends7.3.2 Market Forecast7.4 Polymer7.4.1 Market Trends7.4.2 Market Forecast7.5 Metal7.5.1 Market Trends7.5.2 Market Forecast7.6 Others7.6.1 Market Trends7.6.2 Market Forecast8 Market Breakup by Application8.1 Construction Composites8.1.1 Market Trends8.1.2 Market Forecast8.2 Medical Technology8.2.1 Market Trends8.2.2 Market Forecast8.3 Life Science & Biotechnology8.3.1 Market Trends8.3.2 Market Forecast8.4 Paints & Coatings8.4.1 Market Trends8.4.2 Market Forecast8.5 Cosmetics & Personal Care8.5.1 Market Trends8.5.2 Market Forecast8.6 Oil & Gas8.6.1 Market Trends8.6.2 Market Forecast8.7 Automotive8.7.1 Market Trends8.7.2 Market Forecast8.8 Aerospace8.8.1 Market Trends8.8.2 Market Forecast8.9 Others8.9.1 Market Trends8.9.2 Market Forecast9 Market Breakup by Region9.1 North America9.1.1 Market Trends9.1.2 Market Forecast9.2 Europe9.2.1 Market Trends9.2.2 Market Forecast9.3 Asia Pacific9.3.1 Market Trends9.3.2 Market Forecast9.4 Middle East and Africa9.4.1 Market Trends9.4.2 Market Forecast9.5 Latin America9.5.1 Market Trends9.5.2 Market Forecast10 SWOT Analysis10.1 Overview10.2 Strengths10.3 Weaknesses10.4 Opportunities10.5 Threats11 Value Chain Analysis12 Porter's Five Forces Analysis12.1 Overview12.2 Bargaining Power of Buyers12.3 Bargaining Power of Suppliers12.4 Degree of Competition12.5 Threat of New Entrants12.6 Threat of Substitutes13 Price Analysis14 Competitive Landscape14.1 Market Structure14.2 Key Players14.3 Profiles of Key Players14.3.1 3M14.3.2 AkzoNobel14.3.3 Nouryon14.3.4 Matsumoto Yushi-Seiyaku Company14.3.5 Chase Corporation14.3.6 Trelleborg14.3.7 Momentive Performance Materials14.3.8 Potters Industries14.3.9 Luminex Corporation14.3.10 Merit Medical Systems14.3.11 Bangs Laboratories14.3.12 Cospheric14.3.13 Asia Pacific Microspheres14.3.14 Mo-Sci Corporation14.3.15 Sigmund Lindner14.3.16 SIR-Spheres For more information about this report visit

NEWTOWN SQUARE, Pa., May 10, 2021 /PRNewswire/ -- Ott Scientific is pleased to announce its acquisition of American Bionostica, Inc. (ABI), a lateral flow development and manufacturing company, further diversifying the company's product portfolio within the health-care diagnostics space. The acquisition of American Bionostica Inc. – a leading developer of specialty quantitative lateral flow assays utilizing colloidal gold conjugates and latex microspheres for highly sensitive and specific assays – was effective April 1 and will be operated inside the company's Ethos Biosciences subsidiary. "Through integrating American Bionostica into the Ott Scientific organization, we are driving health-care innovation by providing diagnostic tools to scientists and practitioners," said Ryan Ott, EVP of Ott Scientific and President of Ethos Biosciences. "The addition of ABI broadens the portfolio of assays we develop and manufacture that are accurate, repeatable and easy to use." The entire American Bionostica team will join Ott Scientific post acquisition, and a number of new research and production positions are expected to open immediately. ISO13485 and cGMP compliant space is under construction at Ott Scientific's 126,000-square-foot facility in Logan Township, NJ, to house the operation, which will provide significant room for expansion of the business. ABI will remain at its Swedesboro, NJ, location until the new space is completed later this year. "We are excited to integrate ABI into our portfolio of diagnostic-related companies, expanding the unique products and services we can provide to our customers," said Michael H. Ott, Chairman & CEO of Ott Scientific. "Rapid tests that American Bionostica can develop and manufacture here in the United States have applications in food, environmental, biotechnology and health-care industries." About Ott Scientific Ott Scientific is a leading manufacturer of clinical histology and hematology stains, immunoassays for the research market, and microspheres for the diagnostic market through its subsidiaries Astral Diagnostics, Bangs Laboratories, Ethos Biosciences and Polysciences, Inc. Learn more about Ott Scientific by visiting .